Fresenius Medical Care AG KGaA EBITDA Margin 2010-2024 | FMS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. The current EBITDA margin for Fresenius Medical Care AG KGaA as of September 30, 2024 is .
| Fresenius Medical Care AG KGaA EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $20.87B | $3.54B | 16.95% |
| 2024-06-30 | $21.01B | $3.45B | 16.43% |
| 2024-03-31 | $21.13B | $3.45B | 16.33% |
| 2023-12-31 | $21.06B | $3.38B | 16.04% |
| 2023-09-30 | $20.82B | $3.41B | 16.40% |
| 2023-06-30 | $20.58B | $3.50B | 17.01% |
| 2023-03-31 | $20.38B | $3.42B | 16.78% |
| 2022-12-31 | $20.44B | $3.53B | 17.27% |
| 2022-09-30 | $20.63B | $3.62B | 17.53% |
| 2022-06-30 | $20.73B | $3.73B | 18.01% |
| 2022-03-31 | $20.87B | $3.93B | 18.84% |
| 2021-12-31 | $20.84B | $4.11B | 19.73% |
| 2021-09-30 | $20.79B | $4.27B | 20.53% |
| 2021-06-30 | $20.71B | $4.47B | 21.59% |
| 2021-03-31 | $20.53B | $4.66B | 22.69% |
| 2020-12-31 | $20.40B | $4.67B | 22.90% |
| 2020-09-30 | $20.21B | $4.66B | 23.06% |
| 2020-06-30 | $19.97B | $4.52B | 22.61% |
| 2020-03-31 | $19.83B | $4.36B | 21.98% |
| 2019-12-31 | $19.57B | $4.33B | 22.10% |
| 2019-09-30 | $19.40B | $4.08B | 21.00% |
| 2019-06-30 | $19.21B | $3.78B | 19.66% |
| 2019-03-31 | $19.35B | $4.64B | 23.98% |
| 2018-12-31 | $19.54B | $4.45B | 22.75% |
| 2018-09-30 | $19.87B | $4.32B | 21.72% |
| 2018-06-30 | $20.25B | $4.46B | 22.02% |
| 2018-03-31 | $20.14B | $3.43B | 17.03% |
| 2017-12-31 | $20.10B | $3.50B | 17.42% |
| 2017-09-30 | $19.55B | $3.69B | 18.88% |
| 2017-06-30 | $19.05B | $3.61B | 18.93% |
| 2017-03-31 | $18.55B | $3.59B | 19.34% |
| 2016-12-31 | $17.91B | $3.41B | 19.06% |
| 2016-09-30 | $17.57B | $3.27B | 18.59% |
| 2016-06-30 | $17.20B | $3.19B | 18.56% |
| 2016-03-31 | $16.98B | $3.09B | 18.17% |
| 2015-12-31 | $16.74B | $3.04B | 18.19% |
| 2015-09-30 | $16.71B | $3.05B | 18.25% |
| 2015-06-30 | $16.59B | $3.02B | 18.23% |
| 2015-03-31 | $16.23B | $3.02B | 18.62% |
| 2014-12-31 | $15.83B | $2.95B | 18.65% |
| 2014-09-30 | $15.38B | $2.93B | 19.06% |
| 2014-06-30 | $14.93B | $2.88B | 19.29% |
| 2014-03-31 | $14.71B | $2.85B | 19.35% |
| 2013-12-31 | $14.61B | $2.88B | 19.71% |
| 2013-09-30 | $14.45B | $2.76B | 19.12% |
| 2013-06-30 | $14.20B | $2.76B | 19.44% |
| 2013-03-31 | $14.02B | $2.78B | 19.83% |
| 2012-12-31 | $13.80B | $2.77B | 20.06% |
| 2012-09-30 | $13.42B | $2.78B | 20.70% |
| 2012-06-30 | $13.24B | $2.73B | 20.64% |
| 2012-03-31 | $13.01B | $2.66B | 20.44% |
| 2011-12-31 | $12.80B | $2.60B | 20.33% |
| 2011-09-30 | $12.64B | $2.56B | 20.22% |
| 2011-06-30 | $12.46B | $2.50B | 20.10% |
| 2011-03-31 | $12.21B | $2.45B | 20.10% |
| 2010-12-31 | $12.05B | $2.43B | 20.14% |
| 2010-09-30 | $11.92B | $2.37B | 19.84% |
| 2010-06-30 | $11.75B | $2.32B | 19.72% |
| 2010-03-31 | $11.57B | $2.26B | 19.53% |
| 2009-12-31 | $11.25B | $2.21B | 19.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $13.691B | $21.053B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.416B | 24.94 |
| Intuitive Surgical (ISRG) | United States | $192.946B | 100.88 |
| Alcon (ALC) | Switzerland | $43.080B | 28.83 |
| Edwards Lifesciences (EW) | United States | $41.404B | 26.29 |
| IQVIA Holdings (IQV) | United States | $36.405B | 20.06 |
| IDEXX Laboratories (IDXX) | United States | $35.383B | 41.67 |
| DexCom (DXCM) | United States | $31.603B | 47.59 |
| Waters (WAT) | United States | $22.979B | 33.98 |
| STERIS (STE) | Ireland | $21.385B | 24.62 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.978B | 0.00 |
| Hologic (HOLX) | United States | $17.581B | 18.99 |
| Sysmex ADR (SSMXY) | Japan | $13.362B | 41.90 |
| Globus Medical (GMED) | United States | $11.588B | 29.34 |
| Penumbra (PEN) | United States | $9.412B | 92.19 |
| Masimo (MASI) | United States | $9.326B | 45.13 |
| Teleflex (TFX) | United States | $8.737B | 13.94 |
| Glaukos (GKOS) | United States | $7.499B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.035B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.735B | 26.84 |
| Veracyte (VCYT) | United States | $3.384B | 101.54 |
| Inari Medical (NARI) | United States | $3.018B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.803B | 16.18 |
| Nihon Kohden (NHNKY) | Japan | $2.421B | 18.39 |
| TransMedics (TMDX) | United States | $2.398B | 76.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.192B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.121B | 19.07 |
| Integra LifeSciences Holdings (IART) | United States | $1.901B | 9.93 |
| RxSight (RXST) | United States | $1.756B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.248B | 0.00 |
| Artivion (AORT) | United States | $1.244B | 82.44 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.875B | 14.87 |
| Paragon 28 (FNA) | United States | $0.856B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.739B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 36.74 |
| Mesa Laboratories (MLAB) | United States | $0.668B | 15.75 |
| AxoGen (AXGN) | United States | $0.635B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.634B | 0.00 |
| SiBone (SIBN) | United States | $0.546B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.533B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.527B | 31.04 |
| Pacific Biosciences Of California (PACB) | United States | $0.501B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.453B | 24.53 |
| Delcath Systems (DCTH) | United States | $0.379B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.289B | 0.00 |
| Inogen (INGN) | United States | $0.237B | 0.00 |
| Accuray (ARAY) | United States | $0.211B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.155B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.05 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.092B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.088B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |